| 國家衛生研究院 |
2010-03 |
Cancer care quality assessment in USA, UK and Taiwan
|
Liu, CM;Huang, KC;Chiu, CF;Liu, TW |
| 臺大學術典藏 |
2020-06-11T06:12:01Z |
Cancer cell death pathways caused by photothermal and photodynamic effects through gold nanoring induced surface plasmon resonance
|
He, Y.;Hsiao, J.-H.;Yu, J.-H.;Tseng, P.-H.;Hua, W.-H.;Low, M.-C.;Tsai, Y.-H.;Cai, C.-J.;Hsieh, C.-C.;Kiang, Y.-W.;Yang, C.C.;Zhang, Z.; He, Y.; Hsiao, J.-H.; Yu, J.-H.; Tseng, P.-H.; Hua, W.-H.; Low, M.-C.; Tsai, Y.-H.; Cai, C.-J.; Hsieh, C.-C.; Kiang, Y.-W.; Yang, C.C.; Zhang, Z.; YEAN-WOEI KIANG |
| 臺大學術典藏 |
2018-09-10T06:17:07Z |
Cancer cell filopodia characterized by super-resolution bright-field optical microscopy
|
Lee, C.-H. and Hsu, T.-H. and Liao, W.-Y. and Yang, P.-C. and Wang, C.-C. and Xiao, J.-L.; WEI-YU LIAO |
| 臺大學術典藏 |
2020-07-21T06:09:17Z |
Cancer cell filopodia characterized by super-resolution bright-field optical microscopy
|
Hsu T.-H.; WEI-YU LIAO; Yang P.-C.; Wang C.-C.; Xiao J.-L.; Lee C.-H. |
| 臺大學術典藏 |
2020-07-21T06:09:17Z |
Cancer cell filopodia characterized by super-resolution bright-field optical microscopy
|
Lee C.-H.;Hsu T.-H.;Wei-Yu Liao;Yang P.-C.;Wang C.-C.;Xiao J.-L.; Lee C.-H.; Hsu T.-H.; WEI-YU LIAO; Yang P.-C.; Wang C.-C.; Xiao J.-L. |
| 臺大學術典藏 |
2020-12-02T02:34:40Z |
Cancer cell filopodia characterized by super-resolution bright-field optical microscopy
|
Lee C.-H.; Hsu T.-H.; Liao W.-Y.; Pan-Chyr Yang; Wang C.-C.; Xiao J.-L.; Lee C.-H.; Hsu T.-H.; Liao W.-Y.; PAN-CHYR YANG; Wang C.-C.; Xiao J.-L. |
| 臺大學術典藏 |
2020-12-02T02:34:47Z |
Cancer cell filopodia characterized by super-resolution bright-field optical microscopy
|
Lee C.-H.; Hsu T.-H.; Liao W.-Y.; PAN-CHYR YANG; Wang C.-C.; Xiao J.-L. |
| 臺北醫學大學 |
2015 |
Cancer Cell Gene Expression Modulated from Plasma Membrane Integrin αvβ3 by Thyroid Hormone and Nanoparticulate Tetrac
|
Davis, PJ;Glinsky, GV;Lin, HY;Leith, JT;Hercbergs, A;Tang, HY;Ashur-Fabian, O;Incerpi, S;Mousa, SA |
| 國立交通大學 |
2014-12-08T15:23:46Z |
Cancer cell labeling and tracking using fluorescent and magnetic nanodiamond
|
Lien, Zhi-Yi; Hsu, Tzu-Chia; Liu, Kuang-Kai; Liao, Wei-Siang; Hwang, Kuo-Chu; Chao, Jui-I. |
| 國立東華大學 |
2007-11 |
Cancer cell targeting and therapy by growth hormone-nano-diamond complex
|
Chang Chia-Ching ; Pei-Hsin Chen ; Hsuen-Liang Chu ; Yu-Ching Chang ; Jen-Yin Su ; Jui-I Chao ; Chia-Liang Cheng ; Yen-Peng Ho ; Ken-Wen Sun ; Jyh Shin Chen ; Yin-Chang Liu |
| 國立臺灣大學 |
2008 |
Cancer Cell Targeting Using Multiple Aptamers Conjugated on Nanorods
|
Huang, Yu-Fen; Chang, Huan-Tsung; Tan, Weihong |
| 臺大學術典藏 |
2008 |
Cancer Cell Targeting Using Multiple Aptamers Conjugated on Nanorods
|
Huang, Yu-Fen; Chang, Huan-Tsung; Tan, Weihong; Huang, Yu-Fen; Chang, Huan-Tsung; Tan, Weihong |
| 臺大學術典藏 |
2020-06-11T06:12:05Z |
Cancer cell uptake behavior of Au nanoring and its localized surface plasmon resonance induced cell inactivation
|
Chu, C.-K.;Tu, Y.-C.;Chang, Y.-W.;Chu, C.-K.;Chen, S.-Y.;Chi, T.-T.;Kiang, Y.-W.;Yang, C.-C.; Chu, C.-K.; Tu, Y.-C.; Chang, Y.-W.; Chu, C.-K.; Chen, S.-Y.; Chi, T.-T.; Kiang, Y.-W.; Yang, C.-C.; YEAN-WOEI KIANG |
| 臺大學術典藏 |
2015 |
Cancer cell uptake behavior of Au nanoring and its localized surface plasmon resonance induced cell inactivation
|
Chu, C.-K.; Tu, Y.-C.; Chang, Y.-W.; Chu, C.-K.; Chen, S.-Y.; Chi, T.-T.; Kiang, Y.-W.; Yang, C.-C.; CHIH-CHUNG YANG; Chu, C.-K.;Tu, Y.-C.;Chang, Y.-W.;Chu, C.-K.;Chen, S.-Y.;Chi, T.-T.;Kiang, Y.-W.;Yang, C.-C. |
| 國家衛生研究院 |
2010-09 |
Cancer cells acquire mitotic drug resistance properties through beta i-tubulin mutations and alterations in the expression of beta-tubulin isotypes
|
Cheung, CHA;Wu, SY;Lee, TR;Chang, CY;Wu, JS;Hsieh, HP;Chang, JY |
| 臺大學術典藏 |
2020-06-11T06:32:24Z |
Cancer cells differentiation by multi-color ZnO and TiO2 nanowires
|
Li, W.-J.;Yang, S.-C.;Shen, Y.-C.;Huang, J.-J.;Yang, T.-L.; Li, W.-J.; Yang, S.-C.; Shen, Y.-C.; Huang, J.-J.; Yang, T.-L.; JIAN-JANG HUANG |
| 臺大學術典藏 |
2018-09-10T18:05:41Z |
Cancer cells increase endothelial cell tube formation and survival by activating the PI3K/Akt signalling pathway
|
Cheng, H.-W. And Chen, Y.-F. And Wong, J.-M. And Weng, C.-W. And Chen, H.-Y. And Yu, S.-L. And Chen, H.-W. And Yuan, A. And Chen, J.J.W.; SUNG-LIANG YU; ANG YUAN; HUEI-WEN CHEN |
| 臺大學術典藏 |
2020-06-17T03:01:31Z |
Cancer cells increase endothelial cell tube formation and survival by activating the PI3K/Akt signalling pathway
|
Chen J.J.W.; Yuan A.; Chen H.-W.; Cheng H.-W.;Chen Y.-F.;Wong J.-M.;Weng C.-W.;Chen H.-Y.;Sung-Liang Yu;Chen H.-W.;Yuan A.;Chen J.J.W.; Cheng H.-W.; Chen Y.-F.; Wong J.-M.; Weng C.-W.; Chen H.-Y.; SUNG-LIANG YU |
| 臺大學術典藏 |
2020-03-26T06:54:21Z |
Cancer cells increase endothelial cell tube formation and survival by activating the PI3K/Akt signalling pathway
|
Cheng H.-W.;Chen Y.-F.;Wong J.-M.;Weng C.-W.;Chen H.-Y.;Yu S.-L.;Chen H.-W.;Ang Yuan;Chen J.J.W.; Cheng H.-W.; Chen Y.-F.; Wong J.-M.; Weng C.-W.; Chen H.-Y.; Yu S.-L.; Chen H.-W.; ANG YUAN; Chen J.J.W. |
| 臺大學術典藏 |
2022-03-09T03:12:24Z |
Cancer cells increase endothelial cell tube formation and survival by activating the PI3K/Akt signalling pathway
|
Cheng H.-W.; Chen Y.-F.; Wong J.-M.; Weng C.-W.; Chen H.-Y.; Yu S.-L.; HUEI-WEN CHEN; Yuan A.; Chen J.J.W. |
| 國立臺灣大學 |
1999 |
Cancer Chemoprevention by Tea Polyphenols through Mitotic Signal Blockade , a Commentary
|
林仁混; 梁有志; 蕭水銀; LIN, JEN-KUN; LIANG, YU-CHIH; LIN-SHIAU, SHOEI-YN |
| 臺北醫學大學 |
1999 |
Cancer chemoprevention by tea polyphenols through mitotic signal blockade, a commentary.
|
梁有志; Lin; J.K.; Liang; Y.C. and Lin-Shiau; S.Y. |
| 臺北醫學大學 |
2000 |
Cancer Chemoprevention by Tea Polyphenols- a review.
|
梁有志; Lin; J.K. and Liang; Y.C. |
| 國立臺灣大學 |
2000 |
Cancer Chemoprevention of Cancer by Tea Polyphenols
|
林仁混; 梁有志; LIN, JEN-KUN; LIANG, YU-CHIH |
| 國立成功大學 |
2003-04-25 |
Cancer chemopreventive activity of acridone alkaloids on Epstein-Barr virus activation and two-stage mouse skin carcinogenesis
|
Itoigawa, Masataka; Ito, Chihiro; Wu, Tian-Shung; Enjo, Fumio; Tokuda, Harukuni; Nishino, Hoyoku; Furukawa, Hiroshi |
